Diagnostic Imaging
Conditions
Keywords
Drug utilization review
Brief summary
The purpose of this study is to obtain data on the safety and efficacy of Ultravist application in usual daily use.The radiologist will administer the contrast medium to the patient as he/she would have done without the study. No other examinations will be performed than would have been done routinely.
Interventions
DRUGUltravist (Iopromide, BAY86-4877)
Patients with indication for an X-ray examination and for whom the radiologist has decided to use the contrast medium Ultravist.
Sponsors
Bayer
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Patients with indication for an X-ray examination and for whom the radiologist has decided to use the contrast medium Ultravist.
Exclusion criteria
* No
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Occurrence of adverse events | During and after Ultravist application on the day of examination |
Secondary
| Measure | Time frame |
|---|---|
| General contrast quality in the region of interest as assessed by physicians | On the day of examination |
Countries
Bosnia and Herzegovina, China, Germany, Hungary, Indonesia, Iran, Italy, Malaysia, Moldova, Pakistan, Philippines, Poland, Romania, Russia, Saudi Arabia, Singapore, South Korea, Taiwan, Thailand, Ukraine, Vietnam
Outcome results
None listed